NURS 6630 PSYCHOPHARMACOLOGY
MIDTERM 2026 HIGH-YIELD ANTIDEPRESSANTS
ANTIPSYCHOTICS AND MOOD STABILIZERS
STUDY PACKAGE
◉ Medication used to treat mood disorders.
Answer: Mood Stabilizer
◉ Antidepressant also used for chronic pain.
Answer: Amitriptyline (Elavil)
◉ SSRI antidepressant for depression and anxiety.
Answer: Fluoxetine (Prozac)
◉ Low platelet count caused by medication.
Answer: Drug-Induced Thrombocytopenia
◉ An antidepressant used for mood disorders.
Answer: Amitriptyline (Elavil)
◉ Decreases serotonin and dopamine activity.
,Answer: Inverse agonist
◉ Medications for anxiety and panic disorders.
Answer: Benzodiazepines
◉ Receptors that mediate rapid synaptic transmission.
Answer: Ionotropic receptors
◉ Medication used for smoking cessation.
Answer: Varenicline (Chantix)
◉ Drugs that partially stimulate receptors.
Answer: Partial agonists
◉ Medications used to stabilize mood and treat seizures.
Answer: Anticonvulsants
◉ Channels activated by neurotransmitter binding.
Answer: Ligand-gated ion channels
◉ An SSRI used to treat panic disorder.
Answer: Sertraline
,◉ Used temporarily to manage anxiety symptoms.
Answer: Short-acting benzodiazepine
◉ Medications that prevent mood swings in bipolar disorder.
Answer: Mood stabilizers
◉ Antidepressants with significant food interactions.
Answer: MAO inhibitors
◉ An SSRI with uncommon sedation side effects.
Answer: Fluoxetine
◉ Signs of elevated mood and hyperactivity.
Answer: Manic symptoms
◉ Dopamine receptors targeted by antipsychotics.
Answer: D2 receptors
◉ Involuntary movements from long-term antipsychotic use.
Answer: Tardive dyskinesia
, ◉ Severe increase in blood pressure from food interactions.
Answer: Hypertensive crisis
◉ Receptors involved in serotonin signaling.
Answer: Serotonin 3 receptors
◉ Cholinergic receptors that respond to acetylcholine.
Answer: Nicotinic receptors
◉ Receptors activated by the neurotransmitter acetylcholine.
Answer: Cholinergic receptors
◉ Inhibitory receptors in the central nervous system.
Answer: Glycine receptors
◉ Stimulates dopamine receptors to treat Parkinson's disease.
Answer: Dopamine agonist
◉ Primary binding site for dopamine agonists.
Answer: D2 Receptors
◉ Pathways influencing cognitive symptoms in schizophrenia.
MIDTERM 2026 HIGH-YIELD ANTIDEPRESSANTS
ANTIPSYCHOTICS AND MOOD STABILIZERS
STUDY PACKAGE
◉ Medication used to treat mood disorders.
Answer: Mood Stabilizer
◉ Antidepressant also used for chronic pain.
Answer: Amitriptyline (Elavil)
◉ SSRI antidepressant for depression and anxiety.
Answer: Fluoxetine (Prozac)
◉ Low platelet count caused by medication.
Answer: Drug-Induced Thrombocytopenia
◉ An antidepressant used for mood disorders.
Answer: Amitriptyline (Elavil)
◉ Decreases serotonin and dopamine activity.
,Answer: Inverse agonist
◉ Medications for anxiety and panic disorders.
Answer: Benzodiazepines
◉ Receptors that mediate rapid synaptic transmission.
Answer: Ionotropic receptors
◉ Medication used for smoking cessation.
Answer: Varenicline (Chantix)
◉ Drugs that partially stimulate receptors.
Answer: Partial agonists
◉ Medications used to stabilize mood and treat seizures.
Answer: Anticonvulsants
◉ Channels activated by neurotransmitter binding.
Answer: Ligand-gated ion channels
◉ An SSRI used to treat panic disorder.
Answer: Sertraline
,◉ Used temporarily to manage anxiety symptoms.
Answer: Short-acting benzodiazepine
◉ Medications that prevent mood swings in bipolar disorder.
Answer: Mood stabilizers
◉ Antidepressants with significant food interactions.
Answer: MAO inhibitors
◉ An SSRI with uncommon sedation side effects.
Answer: Fluoxetine
◉ Signs of elevated mood and hyperactivity.
Answer: Manic symptoms
◉ Dopamine receptors targeted by antipsychotics.
Answer: D2 receptors
◉ Involuntary movements from long-term antipsychotic use.
Answer: Tardive dyskinesia
, ◉ Severe increase in blood pressure from food interactions.
Answer: Hypertensive crisis
◉ Receptors involved in serotonin signaling.
Answer: Serotonin 3 receptors
◉ Cholinergic receptors that respond to acetylcholine.
Answer: Nicotinic receptors
◉ Receptors activated by the neurotransmitter acetylcholine.
Answer: Cholinergic receptors
◉ Inhibitory receptors in the central nervous system.
Answer: Glycine receptors
◉ Stimulates dopamine receptors to treat Parkinson's disease.
Answer: Dopamine agonist
◉ Primary binding site for dopamine agonists.
Answer: D2 Receptors
◉ Pathways influencing cognitive symptoms in schizophrenia.
